Anticoagulation strategies for venous thromboembolism.
Venous thromboembolism (VTE) continues to be a major source of morbidity and mortality in the United States with an estimated incidence of greater than 600 000 clinically evident cases each year. It results in more than 200 000 deaths per year and is thought to be the number one cause of preventable in-hospital deaths. This review presents the history, pathophysiology, diagnostic considerations, and treatment options for VTE.
Peterson
David
D
Duke University, Durham, NC, USA.
Harward
Steve
S
Lawson
Jeffrey H
JH
D000925:Anticoagulants / Q000627:therapeutic use*; D001777:Blood Coagulation / Q000187:drug effects*; D049671:History, 18th Century; D049690:History, Ancient; D049691:History, Medieval; D006801:Humans; D015994:Incidence; D010151:Paintings; D013997:Time Factors; D016896:Treatment Outcome; D054556:Venous Thromboembolism / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy* / Q000266:history / Q000401:mortality / Q000503:physiopathology
D000925:Anticoagulants